Instagram NASH Langman

Non-Alcoholic Steatohepatitis (NASH) Trial

Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an investigational drug for treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH).  To qualify, participants must:

  • Be between the ages if 18 and 75
  • Have had liver biopsy or be willing to undergo a liver biopsy

Qualified participants may receive:

  • Compensation for time & travel
  • Study-related care at no cost

For more information, please contact our Clinical Research Coordinator, Samantha Oberdier, at (845) 367-1621 or [email protected]

Contact Us

* All indicated fields must be completed.
Please include non-medical questions and correspondence only.

Office Information

Office Hours

Monday through Friday
Patient Procedures: 8:00AM – 5:00PM
24 hour coverage in case of emergency